SEARCH

SEARCH BY CITATION

References

  • Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:15751583.
  • Agresti A. (2002) Categorical data analysis (Wiley Series in Probability and Statistics). 2nd ed. Wiley-Interscience, Hoboken, NJ.
  • Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, De Vigan C, Lancaster PA, Merlob P, Sumiyoshi Y, Zampino G, Renzi C, Rosano A, Mastroiacovo P. (2000) Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 41:14361443.
  • Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64:18741878.
  • Bertollini R, Mastoiacovo P, Segni G. (1985) Maternal epilepsy and birth defects: a case-control study in the Italian Multicenter Registry of Birth Defects (IPIMC). Eur J Epidemiol 1:6772.
  • Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, Mamoli D, Palmieri C, Molteni F, Granata T, Hassibi P, Zamperini P, Pardi G, Avanzini G. (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:12311236.
  • Chadwick D. (2006) Starting and stopping treatment for seizures and epilepsy. Epilepsia 47(Suppl 1):5861.
  • Eriksson K, Viinikainen K, Mönkkönen A, Aikiä M, Nieminen P, Heinonen S, Kälviäinen R. (2005) Children exposed to valproate in utero – Population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65:189200.
  • Fried S, Kozer E, Nulman I, Einarson TR, Koren G. (2004) Malformation rates in children of women with untreated epilepsy. Drug Saf 27:197202.
  • Gaily E. (1990) Distal phalangeal hypoplasia in children with prenatal phenytoin exposure: results of a controlled anthropometric study. Am J Med Genet 35:574578.
  • Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, Nylund T, Bardy A, Kaaja E, Granström ML. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:2832.
  • Harden CL, Hopp J, Ting TY, Pennell PB, French JA, Hauser WA, Wiebe S, Gronseth GS, Thurman D, Meador KJ, Koppel BS, Kaplan PW, Robinson JN, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Le Guen C. (2009) Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency. Neurology in press.
  • Hiilesmaa VK, Bardy A, Teramo K. (1985) Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 152:499504.
  • Hirano T, Fujioka K, Okada M, Iwasa H, Kaneko S. (2004) Physical and psychomotor development in the offspring born to mothers with epilepsy. Epilepsia 45(Suppl 8):5357.
  • Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. (2007) How common are the “common” neurologic disorders? Neurology 68:326337.
  • Holmes LB, Rosenberger PB, Harvey EA, Khoshbin S, Ryan L. (2000) Intelligence and physical features of children of women with epilepsy. Teratology 61:196202.
  • Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med 344:11321138.
  • Hvas CL, Henriksen TB, Ostergaard JR, Dam M. (2000) Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birth weight. Br J Obstet Gynaecol 107:896902.
  • Koch S, Titze K, Zimmermann RB, Schröder M, Lehmkuhl U, Rauh H. (1999) Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 40:12371243.
  • Laskowska M, Leszczyriska-Gorzelak B, Oleszczuk J. (2001) Pregnancy in women with epilepsy. Gynecol Obstet Invest 51:99102.
  • Lösche G, Steinhausen HC, Koch S, Helge H. (1994) The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 83:961966.
  • Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR, SANAD Study group. (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:10161026.
  • Mawer G, Clayton-Smith J, Coyle H, Kini U. (2002) Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 11:512518.
  • Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC, NEAD Study Group. (2006) In utero antiepileptic drug exposure: fetal death and malformations. Neurology 67:407412.
  • Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. (2006) Malformations risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193198.
  • Omtzigt JG, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H, Stewart PA, Gaillard HL, Sachs ES, Wladimiroff JW. (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42(Suppl 5):119125.
  • Oyen N, Vollset SE, Eide MG, Bjerkedal T, Skjærven R. (2007) Maternal epilepsy and offsprings’ adult intelligence: a population-based study from Norway. Epilepsia 48:17311738.
  • Pilo C, Wide K, Winbladh B. (2006) Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs. Acta Obstet Gynecol Scand 85:643646.
  • Puho EH, Szunyogh M, Metneki J, Czeizel AE. (2007) Drug treatment during pregnancy and isolated orofacial clefts in Hungary. Cleft Palate Craniofac J 4:194202.
  • Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274:15181525.
  • Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. (2004) Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 190:371379.
  • Samrén EB, Van Duijn CM, Christiaens GCML, Hofman A, Lindhout E. (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739746.
  • Samrén EB, Van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, Mannagetta GB, Deichl AW, Gaily E, Granström ML, Meinardi H, Grobbee DE, Hofman A, Janz D, Lindhout D. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38:981990.
  • Sankar R. (2007) Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics. Acta Neurol Scand 117:6571.
  • Sattler JM. (1992) Assessment of Children revd/updated. 3rd ed. Jerome M. Sattler, San Diego.
  • Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, Gladstone R, Ashby P, Weksberg R, Einarson T. (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767770.
  • United States Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Bridged-Race Population Estimates, United States. (2007). July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin on CDC WONDER On-line Database. http://wonder.cdc.gov .
  • Vajda FJ, Hitchcock A, Graham J, Solinas C, O’Brien TJ, Lander CM, Eadie MJ. (2006) Foetal malformations and seizure control:52 months data of the Australian Pregnancy Registry. Eur J Neurol 13:645654.
  • Vanoverloop D, Schnell RR, Harvey EA, Holmes LB. (1992) The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 14:329335.
  • Viinikainen K, Heinonen S, Eriksson K, Kalviainan R. (2006) Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 47:186192.
  • Wide K, Henning E, Tomson T, Winbladh B. (2002) Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91:409414.
  • Wide K, Winbladh B, Kallen B. (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93:17741776.
  • Wilhelm J, Morris D, Hotham N. (1990) Epilepsy and pregnancy – a review of 98 pregnancies. Aust N Z J Obstet Gynaecol 30:290295.
  • Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Homes LB. (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64:961965.
  • Yerby MS. (2000) Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 55:S21S31.